Skip to main content
. 2026 Mar 26;8(Suppl 1):22. doi: 10.1186/s42836-026-00376-9

Table 1 (Abstract P22).

Patient clinical characteristics

Characteristic All patients (31)
Gender 5 (16.13%) males; 26 (83.87%) females
Age (years) 66.26 ± 4.97
BMI (kg/m2) 26.35 ± 3.12
Charlson comorbidity index 4.32 ± 1.9
Pain Duration (years) 9.83 ± 10.27
Postoperative Hospital Stay (days) 3.77 ± 1.33
Total Hospital Stay (days) 9 ± 2.98
Flexion (degrees) 117.58 ± 17.79
Extension (degrees) 5.16 ± 7.5
HKA (degrees) 7.97 ± 8.57
mMPTA (degrees) 84.42 ± 3.78
mLDFA (degrees) 90.22 ± 4.74
JLCA (degrees) 3.69 ± 2.07
Femoral AMA (degrees) 6.5 ± 1.77
K-L Grade Grade 3: 12 (38.71%); Grade 4: 19 (61.29%)
Surgery Duration (minutes) 122.14 ± 24.76
Laterality 19 left (61.29%); 12 right (38.71%)
Femur Distal Medial Resection (mm) 7.65 ± 1.92
Femur Distal Lateral Resection (mm) 6.6 ± 2.31
Femur Posterior Medial Resection (mm) 8.13 ± 1.32
Femur Posterior Lateral Resection (mm) 5.82 ± 2.17
Tibia Medial Resection (mm) 4.66 ± 1.86
Tibia Lateral Resection (mm) 8.08 ± 2.16
Patellar Treatment Retained: 24 (77.42%); Replaced: 7 (22.58%)
Femoral Prosthesis Size 4.71 ± 0.97
Tibial Prosthesis Size 3.81 ± 1.01
Liner Thickness (mm) 7.4 ± 2.16
Preoperative SF-36 PF 32.42 ± 18.97
Preoperative SF-36 RP 16.13 ± 33.26
Preoperative SF-36 BP 39.26 ± 17.26
Preoperative SF-36 GH 55.71 ± 18.42
Preoperative SF-36 VT 57.9 ± 21.09
Preoperative SF-36 SF 50.38 ± 20.94
Preoperative SF-36 RE 39.81 ± 43.4
Preoperative SF-36 MH 68.77 ± 17.45
Preoperative SF-36 HT 69.39 ± 22.1
Preoperative WOMAC 46.41 ± 14.92
Preoperative KSS Function 35.45 ± 14.77
Postoperative KSS Function 38.95 ± 19.89
WBC (109/L) 5.40 ± 1.11
Hemoglobin (g/L) 125.37 ± 18.32
NLR 1.38 ± 0.57
PLR 630.92 ± 207.65
Albumin (g/L) 41.62 ± 2.65
PT (s) 11.42 ± 0.98
APTT (s) 28.35 ± 3.03
Fibrinogen (g/L) 2.67 ± 0.55
ESR (mm/h) 8.42 ± 5.3
IL-6 (pg/mL) 4.23 ± 3.77
CRP (mg/dL) 0.12 ± 0.09
Uric Acid (μmol/L) 256.37 ± 63.54
RDW (%) 12.32 ± 0.63
INR 0.99 ± 0.07
Sodium (mmol/L) 141.54 ± 2.91